Old Web
English
Sign In
Acemap
>
authorDetail
>
Min-Jie Li
Min-Jie Li
Centers for Disease Control and Prevention
Vaccination
Medicine
Internal medicine
Seroconversion
Virology
4
Papers
144
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.
2021
Lancet Infectious Diseases
Zhi-Wei Wu
Yaling Hu
Miao Xu
Zhen Chen
Wanqi Yang
Zhiwei Jiang
Min-Jie Li
Hui Jin
Guo-Liang Cui
Panpan Chen
Lei Wang
Guoqing Zhao
Yuzhu Ding
Yu-Liang Zhao
Weidong Yin
Show All
Source
Cite
Save
Citations (139)
Safety, Tolerability and Immunogenicity of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Healthy Children and Adolescents: A Randomised, Double-Blind, and Placebo-Controlled, Phase 1/2 Clinical Trial
2021
Social Science Research Network
Bi-Hua Han
Yufei Song
Changgui Li
Wanqi Yang
Qingxia Ma
Zhiwei Jiang
Min-Jie Li
Xiao-Juan Lian
Wenbin Jiao
Lei Wang
Qun-shu
Zhi-Wei Wu
Yu-Liang Zhao
Qi Li
Qiang Gao
Show All
Source
Cite
Save
Citations (3)
Immune response to different types of hepatitis B vaccine booster doses 2 to 32 years after the primary immunization schedule and its influencing factors
2020
International Journal of Infectious Diseases
Yu-Liang Zhao
Lu-Lu Pan
Zhi-Yong Hao
Fei Jin
Yan-Hong Zhang
Min-Jie Li
Xin-Jiang Zhang
Bi-Hua Han
Hai-Song Zhou
Tian-Li Ma
Feng Wang
Jing-Chen Ma
Li-Peng Shen
Qi Li
Show All
Source
Cite
Save
Citations (0)
Long-term protection at 20- to 31-years after primary vaccination with plasma-derived hepatitis B vaccine in a Chinese rural community
2019
Human Vaccines & Immunotherapeutics
Jing-Chen Ma
Zhi-Wei Wu
Hai-Song Zhou
Zhao Gao
Zhi-Yong Hao
Fei Jin
Yan-Hong Zhang
Min-Jie Li
Feng Wang
Qi Li
Shengli Bi
Yu-Liang Zhao
Show All
Source
Cite
Save
Citations (2)
1